Kathleen Stoll
Kathleen Stoll
certainly company financing involved raises serious
It certainly raises a lot of serious questions, with a pharmaceutical company involved in financing the development of a Medicaid (reform plan).
healthy medical money needs people plans save
These plans will save healthy people money but will be costly for people with more medical needs more.
increased number past several uninsured
Had it not been for these (government) programs, the number of uninsured would have increased even more in each of the past several years.
billion cuts medicare moving program table wrong
Right now we have $10 billion in cuts on the table for the Medicare program in the U.S. Congress. So we're moving in the wrong direction.
companies fear highly people poor profitable rather savings
Our fear is that the savings will be on the back of poor people rather than highly profitable pharmaceutical companies and highly profitable abusive providers.
access care children covers doctor leave moms room waiting
It covers the kids, but it may leave the moms in the waiting room who care for the children without access to the doctor if she's sick.
affordable arise ethical fee moral pay provider questions requires serious
There are serious moral and ethical questions that arise when a provider requires you to pay a fee that may not be affordable for everyone.
happening helping offset programs public seeing
We're seeing how public programs are helping offset what is happening on the employer-based side.